 | • レポートコード：QYR2104Z4251 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、オリゴヌクレオチドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（DNAオリゴ、RNAオリゴ）、用途別市場規模（製薬、研究、診断）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・オリゴヌクレオチドの市場動向 ・企業の競争状況、市場シェア ・オリゴヌクレオチドの種類別市場規模（DNAオリゴ、RNAオリゴ） ・オリゴヌクレオチドの用途別市場規模（製薬、研究、診断） ・オリゴヌクレオチドの北米市場規模2016-2027（アメリカ、カナダ） ・オリゴヌクレオチドのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・オリゴヌクレオチドのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・オリゴヌクレオチドの中南米市場規模2016-2027（メキシコ、ブラジル） ・オリゴヌクレオチドの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Integrated DNA Technologies、Agilent、Sigma-aldrich、Eurofins Genomics、L.G.C Biosearch Technologies、Eurogentec S.A、Nitto Denko Avecia Inc、GenScript、BBI Life Sciences、GeneDesign、TriLink BioTechnologies、SGS DNA、LC Sciences、Twist Bioscience、Creative Biogene、General Biosystems） ・結論 |
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Oligonucleotide is widely used in Research, Pharmaceutical and Diagnostic. The most proportion of Oligonucleotide used in Research, and the revenue in 2018 is 409.97 M USD. Moreover, increase in focus on targeted gene therapies has revolutionized treatment of incurable conditions caused by genetic mutations. Increase in demand for sequencing applications by clinical, diagnostic, academic, and drug development is witnessed by manufactures.
Market Analysis and Insights: Global Oligonucleotides Market
The global Oligonucleotides market size is projected to reach US$ 1909.5 million by 2026, from US$ 1018 million in 2019, at a CAGR of 10.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oligonucleotides market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oligonucleotides market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oligonucleotides market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oligonucleotides market.
Global Oligonucleotides Scope and Market Size
Oligonucleotides market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oligonucleotides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
DNA Oligos
RNA Oligos
Segment by Application
Pharmaceutical
Research
Diagnostic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
Eurofins Genomics
L.G.C Biosearch Technologies
SGS DNA
LC Sciences
Twist Bioscience
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotides Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 DNA Oligos
1.2.3 RNA Oligos
1.3 Market by Application
1.3.1 Global Oligonucleotides Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical
1.3.3 Research
1.3.4 Diagnostic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotides Market Perspective (2016-2027)
2.2 Oligonucleotides Growth Trends by Regions
2.2.1 Oligonucleotides Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oligonucleotides Historic Market Share by Regions (2016-2021)
2.2.3 Oligonucleotides Forecasted Market Size by Regions (2022-2027)
2.3 Oligonucleotides Industry Dynamic
2.3.1 Oligonucleotides Market Trends
2.3.2 Oligonucleotides Market Drivers
2.3.3 Oligonucleotides Market Challenges
2.3.4 Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotides Players by Revenue
3.1.1 Global Top Oligonucleotides Players by Revenue (2016-2021)
3.1.2 Global Oligonucleotides Revenue Market Share by Players (2016-2021)
3.2 Global Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oligonucleotides Revenue
3.4 Global Oligonucleotides Market Concentration Ratio
3.4.1 Global Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotides Revenue in 2020
3.5 Oligonucleotides Key Players Head office and Area Served
3.6 Key Players Oligonucleotides Product Solution and Service
3.7 Date of Enter into Oligonucleotides Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotides Breakdown Data by Type
4.1 Global Oligonucleotides Historic Market Size by Type (2016-2021)
4.2 Global Oligonucleotides Forecasted Market Size by Type (2022-2027)
5 Oligonucleotides Breakdown Data by Application
5.1 Global Oligonucleotides Historic Market Size by Application (2016-2021)
5.2 Global Oligonucleotides Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oligonucleotides Market Size (2016-2027)
6.2 North America Oligonucleotides Market Size by Type
6.2.1 North America Oligonucleotides Market Size by Type (2016-2021)
6.2.2 North America Oligonucleotides Market Size by Type (2022-2027)
6.2.3 North America Oligonucleotides Market Size by Type (2016-2027)
6.3 North America Oligonucleotides Market Size by Application
6.3.1 North America Oligonucleotides Market Size by Application (2016-2021)
6.3.2 North America Oligonucleotides Market Size by Application (2022-2027)
6.3.3 North America Oligonucleotides Market Size by Application (2016-2027)
6.4 North America Oligonucleotides Market Size by Country
6.4.1 North America Oligonucleotides Market Size by Country (2016-2021)
6.4.2 North America Oligonucleotides Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Oligonucleotides Market Size (2016-2027)
7.2 Europe Oligonucleotides Market Size by Type
7.2.1 Europe Oligonucleotides Market Size by Type (2016-2021)
7.2.2 Europe Oligonucleotides Market Size by Type (2022-2027)
7.2.3 Europe Oligonucleotides Market Size by Type (2016-2027)
7.3 Europe Oligonucleotides Market Size by Application
7.3.1 Europe Oligonucleotides Market Size by Application (2016-2021)
7.3.2 Europe Oligonucleotides Market Size by Application (2022-2027)
7.3.3 Europe Oligonucleotides Market Size by Application (2016-2027)
7.4 Europe Oligonucleotides Market Size by Country
7.4.1 Europe Oligonucleotides Market Size by Country (2016-2021)
7.4.2 Europe Oligonucleotides Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotides Market Size (2016-2027)
8.2 Asia-Pacific Oligonucleotides Market Size by Type
8.2.1 Asia-Pacific Oligonucleotides Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oligonucleotides Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oligonucleotides Market Size by Type (2016-2027)
8.3 Asia-Pacific Oligonucleotides Market Size by Application
8.3.1 Asia-Pacific Oligonucleotides Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oligonucleotides Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oligonucleotides Market Size by Application (2016-2027)
8.4 Asia-Pacific Oligonucleotides Market Size by Region
8.4.1 Asia-Pacific Oligonucleotides Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oligonucleotides Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oligonucleotides Market Size (2016-2027)
9.2 Latin America Oligonucleotides Market Size by Type
9.2.1 Latin America Oligonucleotides Market Size by Type (2016-2021)
9.2.2 Latin America Oligonucleotides Market Size by Type (2022-2027)
9.2.3 Latin America Oligonucleotides Market Size by Type (2016-2027)
9.3 Latin America Oligonucleotides Market Size by Application
9.3.1 Latin America Oligonucleotides Market Size by Application (2016-2021)
9.3.2 Latin America Oligonucleotides Market Size by Application (2022-2027)
9.3.3 Latin America Oligonucleotides Market Size by Application (2016-2027)
9.4 Latin America Oligonucleotides Market Size by Country
9.4.1 Latin America Oligonucleotides Market Size by Country (2016-2021)
9.4.2 Latin America Oligonucleotides Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotides Market Size (2016-2027)
10.2 Middle East & Africa Oligonucleotides Market Size by Type
10.2.1 Middle East & Africa Oligonucleotides Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oligonucleotides Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oligonucleotides Market Size by Type (2016-2027)
10.3 Middle East & Africa Oligonucleotides Market Size by Application
10.3.1 Middle East & Africa Oligonucleotides Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oligonucleotides Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oligonucleotides Market Size by Application (2016-2027)
10.4 Middle East & Africa Oligonucleotides Market Size by Country
10.4.1 Middle East & Africa Oligonucleotides Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oligonucleotides Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Integrated DNA Technologies
11.1.1 Integrated DNA Technologies Company Details
11.1.2 Integrated DNA Technologies Business Overview
11.1.3 Integrated DNA Technologies Oligonucleotides Introduction
11.1.4 Integrated DNA Technologies Revenue in Oligonucleotides Business (2016-2021)
11.1.5 Integrated DNA Technologies Recent Development
11.2 Agilent
11.2.1 Agilent Company Details
11.2.2 Agilent Business Overview
11.2.3 Agilent Oligonucleotides Introduction
11.2.4 Agilent Revenue in Oligonucleotides Business (2016-2021)
11.2.5 Agilent Recent Development
11.3 Sigma-aldrich
11.3.1 Sigma-aldrich Company Details
11.3.2 Sigma-aldrich Business Overview
11.3.3 Sigma-aldrich Oligonucleotides Introduction
11.3.4 Sigma-aldrich Revenue in Oligonucleotides Business (2016-2021)
11.3.5 Sigma-aldrich Recent Development
11.4 Eurofins Genomics
11.4.1 Eurofins Genomics Company Details
11.4.2 Eurofins Genomics Business Overview
11.4.3 Eurofins Genomics Oligonucleotides Introduction
11.4.4 Eurofins Genomics Revenue in Oligonucleotides Business (2016-2021)
11.4.5 Eurofins Genomics Recent Development
11.5 L.G.C Biosearch Technologies
11.5.1 L.G.C Biosearch Technologies Company Details
11.5.2 L.G.C Biosearch Technologies Business Overview
11.5.3 L.G.C Biosearch Technologies Oligonucleotides Introduction
11.5.4 L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2016-2021)
11.5.5 L.G.C Biosearch Technologies Recent Development
11.6 Eurogentec S.A
11.6.1 Eurogentec S.A Company Details
11.6.2 Eurogentec S.A Business Overview
11.6.3 Eurogentec S.A Oligonucleotides Introduction
11.6.4 Eurogentec S.A Revenue in Oligonucleotides Business (2016-2021)
11.6.5 Eurogentec S.A Recent Development
11.7 Nitto Denko Avecia Inc
11.7.1 Nitto Denko Avecia Inc Company Details
11.7.2 Nitto Denko Avecia Inc Business Overview
11.7.3 Nitto Denko Avecia Inc Oligonucleotides Introduction
11.7.4 Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2016-2021)
11.7.5 Nitto Denko Avecia Inc Recent Development
11.8 GenScript
11.8.1 GenScript Company Details
11.8.2 GenScript Business Overview
11.8.3 GenScript Oligonucleotides Introduction
11.8.4 GenScript Revenue in Oligonucleotides Business (2016-2021)
11.8.5 GenScript Recent Development
11.9 BBI Life Sciences
11.9.1 BBI Life Sciences Company Details
11.9.2 BBI Life Sciences Business Overview
11.9.3 BBI Life Sciences Oligonucleotides Introduction
11.9.4 BBI Life Sciences Revenue in Oligonucleotides Business (2016-2021)
11.9.5 BBI Life Sciences Recent Development
11.10 GeneDesign
11.10.1 GeneDesign Company Details
11.10.2 GeneDesign Business Overview
11.10.3 GeneDesign Oligonucleotides Introduction
11.10.4 GeneDesign Revenue in Oligonucleotides Business (2016-2021)
11.10.5 GeneDesign Recent Development
11.11 TriLink BioTechnologies
11.11.1 TriLink BioTechnologies Company Details
11.11.2 TriLink BioTechnologies Business Overview
11.11.3 TriLink BioTechnologies Oligonucleotides Introduction
11.11.4 TriLink BioTechnologies Revenue in Oligonucleotides Business (2016-2021)
11.11.5 TriLink BioTechnologies Recent Development
11.12 SGS DNA
11.12.1 SGS DNA Company Details
11.12.2 SGS DNA Business Overview
11.12.3 SGS DNA Oligonucleotides Introduction
11.12.4 SGS DNA Revenue in Oligonucleotides Business (2016-2021)
11.12.5 SGS DNA Recent Development
11.13 LC Sciences
11.13.1 LC Sciences Company Details
11.13.2 LC Sciences Business Overview
11.13.3 LC Sciences Oligonucleotides Introduction
11.13.4 LC Sciences Revenue in Oligonucleotides Business (2016-2021)
11.13.5 LC Sciences Recent Development
11.14 Twist Bioscience
11.14.1 Twist Bioscience Company Details
11.14.2 Twist Bioscience Business Overview
11.14.3 Twist Bioscience Oligonucleotides Introduction
11.14.4 Twist Bioscience Revenue in Oligonucleotides Business (2016-2021)
11.14.5 Twist Bioscience Recent Development
11.15 Creative Biogene
11.15.1 Creative Biogene Company Details
11.15.2 Creative Biogene Business Overview
11.15.3 Creative Biogene Oligonucleotides Introduction
11.15.4 Creative Biogene Revenue in Oligonucleotides Business (2016-2021)
11.15.5 Creative Biogene Recent Development
11.16 General Biosystems
11.16.1 General Biosystems Company Details
11.16.2 General Biosystems Business Overview
11.16.3 General Biosystems Oligonucleotides Introduction
11.16.4 General Biosystems Revenue in Oligonucleotides Business (2016-2021)
11.16.5 General Biosystems Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Oligonucleotides Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of DNA Oligos
Table 3. Key Players of RNA Oligos
Table 4. Global Oligonucleotides Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Oligonucleotides Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oligonucleotides Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Oligonucleotides Market Share by Regions (2016-2021)
Table 8. Global Oligonucleotides Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Oligonucleotides Market Share by Regions (2022-2027)
Table 10. Oligonucleotides Market Trends
Table 11. Oligonucleotides Market Drivers
Table 12. Oligonucleotides Market Challenges
Table 13. Oligonucleotides Market Restraints
Table 14. Global Oligonucleotides Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Oligonucleotides Market Share by Players (2016-2021)
Table 16. Global Top Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotides as of 2020)
Table 17. Ranking of Global Top Oligonucleotides Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Oligonucleotides Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oligonucleotides Product Solution and Service
Table 21. Date of Enter into Oligonucleotides Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Oligonucleotides Revenue Market Share by Type (2016-2021)
Table 25. Global Oligonucleotides Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Oligonucleotides Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Oligonucleotides Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Oligonucleotides Revenue Market Share by Application (2016-2021)
Table 29. Global Oligonucleotides Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Oligonucleotides Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Oligonucleotides Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Oligonucleotides Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Oligonucleotides Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Oligonucleotides Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Oligonucleotides Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Oligonucleotides Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Oligonucleotides Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oligonucleotides Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Oligonucleotides Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Oligonucleotides Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Oligonucleotides Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Oligonucleotides Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Oligonucleotides Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oligonucleotides Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Oligonucleotides Market Size by Country (2022-2027) & (US$ Million)
Table 61. Integrated DNA Technologies Company Details
Table 62. Integrated DNA Technologies Business Overview
Table 63. Integrated DNA Technologies Oligonucleotides Product
Table 64. Integrated DNA Technologies Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 65. Integrated DNA Technologies Recent Development
Table 66. Agilent Company Details
Table 67. Agilent Business Overview
Table 68. Agilent Oligonucleotides Product
Table 69. Agilent Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 70. Agilent Recent Development
Table 71. Sigma-aldrich Company Details
Table 72. Sigma-aldrich Business Overview
Table 73. Sigma-aldrich Oligonucleotides Product
Table 74. Sigma-aldrich Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 75. Sigma-aldrich Recent Development
Table 76. Eurofins Genomics Company Details
Table 77. Eurofins Genomics Business Overview
Table 78. Eurofins Genomics Oligonucleotides Product
Table 79. Eurofins Genomics Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 80. Eurofins Genomics Recent Development
Table 81. L.G.C Biosearch Technologies Company Details
Table 82. L.G.C Biosearch Technologies Business Overview
Table 83. L.G.C Biosearch Technologies Oligonucleotides Product
Table 84. L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 85. L.G.C Biosearch Technologies Recent Development
Table 86. Eurogentec S.A Company Details
Table 87. Eurogentec S.A Business Overview
Table 88. Eurogentec S.A Oligonucleotides Product
Table 89. Eurogentec S.A Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 90. Eurogentec S.A Recent Development
Table 91. Nitto Denko Avecia Inc Company Details
Table 92. Nitto Denko Avecia Inc Business Overview
Table 93. Nitto Denko Avecia Inc Oligonucleotides Product
Table 94. Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 95. Nitto Denko Avecia Inc Recent Development
Table 96. GenScript Company Details
Table 97. GenScript Business Overview
Table 98. GenScript Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 99. GenScript Recent Development
Table 100. BBI Life Sciences Company Details
Table 101. BBI Life Sciences Business Overview
Table 102. BBI Life Sciences Oligonucleotides Product
Table 103. BBI Life Sciences Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 104. BBI Life Sciences Recent Development
Table 105. GeneDesign Company Details
Table 106. GeneDesign Business Overview
Table 107. GeneDesign Oligonucleotides Product
Table 108. GeneDesign Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 109. GeneDesign Recent Development
Table 110. TriLink BioTechnologies Company Details
Table 111. TriLink BioTechnologies Business Overview
Table 112. TriLink BioTechnologies Oligonucleotides Product
Table 113. TriLink BioTechnologies Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 114. TriLink BioTechnologies Recent Development
Table 115. SGS DNA Company Details
Table 116. SGS DNA Business Overview
Table 117. SGS DNA Oligonucleotides Product
Table 118. SGS DNA Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 119. SGS DNA Recent Development
Table 120. LC Sciences Company Details
Table 121. LC Sciences Business Overview
Table 122. LC Sciences Oligonucleotides Product
Table 123. LC Sciences Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 124. LC Sciences Recent Development
Table 125. Twist Bioscience Company Details
Table 126. Twist Bioscience Business Overview
Table 127. Twist Bioscience Oligonucleotides Product
Table 128. Twist Bioscience Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 129. Twist Bioscience Recent Development
Table 130. Creative Biogene Company Details
Table 131. Creative Biogene Business Overview
Table 132. Creative Biogene Oligonucleotides Product
Table 133. Creative Biogene Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 134. Creative Biogene Recent Development
Table 135. General Biosystems Company Details
Table 136. General Biosystems Business Overview
Table 137. General Biosystems Oligonucleotides Product
Table 138. General Biosystems Revenue in Oligonucleotides Business (2016-2021) & (US$ Million)
Table 139. General Biosystems Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oligonucleotides Market Share by Type: 2020 VS 2027
Figure 2. DNA Oligos Features
Figure 3. RNA Oligos Features
Figure 4. Global Oligonucleotides Market Share by Application: 2020 VS 2027
Figure 5. Pharmaceutical Case Studies
Figure 6. Research Case Studies
Figure 7. Diagnostic Case Studies
Figure 8. Oligonucleotides Report Years Considered
Figure 9. Global Oligonucleotides Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Oligonucleotides Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Oligonucleotides Market Share by Regions: 2020 VS 2027
Figure 12. Global Oligonucleotides Market Share by Regions (2022-2027)
Figure 13. Global Oligonucleotides Market Share by Players in 2020
Figure 14. Global Top Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotides as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Oligonucleotides Revenue in 2020
Figure 16. Global Oligonucleotides Revenue Market Share by Type (2016-2021)
Figure 17. Global Oligonucleotides Revenue Market Share by Type (2022-2027)
Figure 18. North America Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Oligonucleotides Market Share by Type (2016-2027)
Figure 20. North America Oligonucleotides Market Share by Application (2016-2027)
Figure 21. North America Oligonucleotides Market Share by Country (2016-2027)
Figure 22. United States Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Oligonucleotides Market Share by Type (2016-2027)
Figure 26. Europe Oligonucleotides Market Share by Application (2016-2027)
Figure 27. Europe Oligonucleotides Market Share by Country (2016-2027)
Figure 28. Germany Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Oligonucleotides Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Oligonucleotides Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Oligonucleotides Market Share by Region (2016-2027)
Figure 38. China Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Oligonucleotides Market Share by Type (2016-2027)
Figure 46. Latin America Oligonucleotides Market Share by Application (2016-2027)
Figure 47. Latin America Oligonucleotides Market Share by Country (2016-2027)
Figure 48. Mexico Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Oligonucleotides Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Oligonucleotides Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Oligonucleotides Market Share by Country (2016-2027)
Figure 54. Turkey Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 58. Agilent Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 59. Sigma-aldrich Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 60. Eurofins Genomics Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 61. L.G.C Biosearch Technologies Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 62. Eurogentec S.A Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 63. Nitto Denko Avecia Inc Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 64. GenScript Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 65. BBI Life Sciences Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 66. GeneDesign Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 67. TriLink BioTechnologies Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 68. SGS DNA Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 69. LC Sciences Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 70. Twist Bioscience Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 71. Creative Biogene Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 72. General Biosystems Revenue Growth Rate in Oligonucleotides Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のオリゴヌクレオチド合成市場規模・現状・予測（2021年-2027年） Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the de…- 世界のオリゴヌクレオチド合成市場規模・現状・予測（2021年-2027年） Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the de…
- 世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals. Market Analysis and Insights: Global Crohn…
- 世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals. Market Analysis and Insights: Global Crohn…
- 世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Crohn's Disease Diagnostic and Therapeutic Market The global Crohn's Disease Diagnostic and Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…